IGM BIOSCIENCES INC's ticker is IGMS and the CUSIP is 449585108. A total of 108 filers reported holding IGM BIOSCIENCES INC in Q2 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $295,256 | -2.4% | 35,360 | +7.9% | 0.00% | – |
| Q2 2023 | $302,467 | -15.0% | 32,770 | +26.5% | 0.00% | – |
| Q1 2023 | $355,866 | -19.2% | 25,900 | 0.0% | 0.00% | – |
| Q4 2022 | $440,559 | -20.2% | 25,900 | +6.6% | 0.00% | – |
| Q3 2022 | $552,000 | +22.9% | 24,296 | -2.4% | 0.00% | – |
| Q2 2022 | $449,000 | +12.0% | 24,900 | +66.0% | 0.00% | – |
| Q1 2022 | $401,000 | -8.9% | 15,000 | 0.0% | 0.00% | – |
| Q4 2021 | $440,000 | -55.4% | 15,000 | 0.0% | 0.00% | – |
| Q3 2021 | $986,000 | -23.6% | 15,000 | -3.2% | 0.00% | -100.0% |
| Q2 2021 | $1,290,000 | +40.2% | 15,500 | +29.2% | 0.00% | – |
| Q1 2021 | $920,000 | -19.9% | 12,000 | -7.7% | 0.00% | -100.0% |
| Q4 2020 | $1,148,000 | +18.7% | 13,000 | -0.8% | 0.00% | 0.0% |
| Q3 2020 | $967,000 | +20.4% | 13,100 | +19.1% | 0.00% | – |
| Q2 2020 | $803,000 | +72.3% | 11,000 | +32.5% | 0.00% | – |
| Q1 2020 | $466,000 | – | 8,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 2,971,542 | $24,812,376 | 1.18% |
| GREAT POINT PARTNERS LLC | 615,317 | $5,137,897 | 0.94% |
| Artal Group S.A. | 2,522,244 | $21,061 | 0.90% |
| Opaleye Management Inc. | 261,000 | $2,179,350 | 0.71% |
| Samsara BioCapital, LLC | 154,664 | $1,291,444 | 0.40% |
| Bruce & Co., Inc. | 120,000 | $1,002,000 | 0.34% |
| Rhenman & Partners Asset Management AB | 200,000 | $1,670,000 | 0.18% |
| Eagle Bay Advisors LLC | 44,635 | $372,702 | 0.17% |
| RA Capital Management | 937,500 | $7,828,125 | 0.15% |
| Baker Brothers Advisors | 3,157,764 | $26,367,329 | 0.15% |